Together with collaborators, we have reported that the EYA4 gene is hypermethylated in the first intron–exon junction [15], and possibly over-expressed in triple-negative breast cancer patients, which correlates with publicly available TCGA dataset that shows amplification as the most common alteration in breast cancer patients. Here, EYA4 is linked to breast carcinoma.